Cargando…

Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2

The coronavirus disease 2019 (COVID-19) pandemic has highlighted the potential therapeutic value of early passive polyclonal immunotherapy using high-titer convalescent plasma (CCP). Human polyclonal hyperimmune immunoglobulin (HIG) has several advantages over CCP. Unlike CCP, HIG can provide standa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burnouf, Thierry, Gathof, Birgit, Bloch, Evan M., Bazin, Renée, de Angelis, Vincenzo, Patidar, Gopal Kumar, Rastvorceva, Rada M. Grubovic, Oreh, Adaeze, Goel, Ruchika, Rahimi-Levene, Naomi, Hindawi, Salwa, Al-Riyami, Arwa Z., So-Osman, Cynthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183240/ https://www.ncbi.nlm.nih.gov/pubmed/35879213 http://dx.doi.org/10.1016/j.tmrv.2022.06.001

Ejemplares similares

Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients—An Open-Label Phase II Clinical Trial
por: Grubovic Rastvorceva, Rada M., et al.
Publicado: (2022)

Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
por: de Alwis, Ruklanthi, et al.
Publicado: (2020)

The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19
por: Focosi, Daniele, et al.
Publicado: (2021)

Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
por: Oestereich, Lisa, et al.
Publicado: (2023)

Hyperimmune Globulins for the Management of Infectious Diseases
por: Pati, Ilaria, et al.
Publicado: (2023)

Analysis of Factors that Influence Hematopoietic Recovery in Autologous Transplanted Patients with Hematopoietic Stem Cells from Peripheral Blood
por: Grubovic, Rada M., et al.
Publicado: (2017)

Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19
por: Alape-Girón, Alberto, et al.
Publicado: (2021)

Coronavirus disease (COVID-19) and acute nonicteric hepatitis: A case report from Asokoro, Nigeria
por: Akerele, Isaac O., et al.
Publicado: (2021)

ANTI-DNA ANTIBODIES IN HYPERIMMUNIZED RABBITS
por: Christian, Charles L., et al.
Publicado: (1965)

Clinical use of Convalescent Plasma in the COVID‐19 pandemic: a transfusion‐focussed gap analysis with recommendations for future research priorities
por: Al‐Riyami, Arwa Z., et al.
Publicado: (2020)

RHEUMATOID FACTOR PROPERTIES OF HYPERIMMUNE RABBIT SERA
por: Christian, Charles L.
Publicado: (1963)

Pregnancy-associated myocardial infarction following elective caesarean section for two previous caesarean sections and myomectomy
por: Oreh, Adaeze Chidinma, et al.
Publicado: (2020)

GAMMA GLOBULIN TURNOVER IN RABBITS BEFORE AND DURING HYPERIMMUNIZATION
por: Andersen, Stig Bryde, et al.
Publicado: (1964)

Prevention and Treatment of Influenza with Hyperimmune Bovine Colostrum Antibody
por: Ng, Wy Ching, et al.
Publicado: (2010)

Herd immunity: hyperimmune globulins for the 21st century
por: Elliott, Sarah TC, et al.
Publicado: (2018)

Anti-SARS-CoV-2 hyperimmune plasma workflow
por: Annamaria, Petrungaro, et al.
Publicado: (2020)

Neonatal foals and hyperimmunized egg protein—A viable therapy?
por: Bennett-Steward, Kristina
Publicado: (2002)

Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
por: Chavda, Vivek P., et al.
Publicado: (2023)

OCCURRENCE OF 19S AND 7S ANTI-IGGS DURING HYPERIMMUNIZATION OF RABBITS WITH STREPTOCOCCI
por: Bokisch, Viktor A., et al.
Publicado: (1972)

CHARACTERISTICS OF STREPTOCOCCAL GROUP-SPECIFIC ANTIBODY ISOLATED FROM HYPERIMMUNE RABBITS
por: Osterland, C. Kirk, et al.
Publicado: (1966)

Wilson disease — the impact of hyperimmunity on disease activity: A case report
por: Stremmel, Wolfgang, et al.
Publicado: (2021)

Generation of recombinant hyperimmune globulins from diverse B-cell repertoires
por: Keating, Sheila M., et al.
Publicado: (2021)

Cochrane corner: convalescent plasma or hyperimmune immunoglobulin for people with COVID-19
por: Nnaji, Chukwudi Arnest, et al.
Publicado: (2020)

Transfusion reaction to hyperimmune plasma in patients with severe COVID-19 infection()
por: Edroso Jarne, Paloma Eugenia, et al.
Publicado: (2021)

Serum proteins and electrophoretic profile in horses undergoing crotalid venom hyperimmunization
por: RAMOS, Monique Gonçalves dos Santos Novelino, et al.
Publicado: (2022)

Novel insights in the clinical management of hyperimmune patients before and after transplantation
por: Grimaldi, Vincenzo, et al.
Publicado: (2023)

Accidental kerosene oil ingestion in under-five age children in Nigeria – The need for vigilance in primary care settings in low- and middle-income countries (LMICs)
por: Oreh, Adaeze C., et al.
Publicado: (2023)

Evaluation of the impact of polyclonal infection and heteroresistance on treatment of tuberculosis patients
por: Kargarpour Kamakoli, Mansour, et al.
Publicado: (2017)

Equine hyperimmune serum protects mice against Clostridium difficile spore challenge
por: Yan, Weiwei, et al.
Publicado: (2014)

In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens
por: Rossmann, F. S., et al.
Publicado: (2014)

Production of the First Effective Hyperimmune Equine Serum Antivenom against Africanized Bees
por: Santos, Keity Souza, et al.
Publicado: (2013)

The CHIR Score for Evaluating the Hyperimmune Response in COVID-19: A Preliminary Concept
por: Goyal, Daniel Kumar, et al.
Publicado: (2020)

Anti-SARS-CoV-2 hyperimmune immunoglobulins, an urgent strategic choice
Publicado: (2020)

Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2
por: Aston, Emily J., et al.
Publicado: (2022)

MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity
por: Gelzo, Monica, et al.
Publicado: (2022)

Biweekly Versus Monthly Hyperimmune Globulin Therapy for Primary Cytomegalovirus Infection in Pregnancy
por: Schirwani-Hartl, Nawa, et al.
Publicado: (2023)

Resistant prolactinoma: Is it monoclonal or polyclonal?
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)

Immune cell kinetics in the ovine abomasal mucosa following hyperimmunization and challenge with Haemonchus contortus
por: Robinson, Nicholas, et al.
Publicado: (2010)

The Use of Hyperimmune Chicken Reference Sera Is Not Appropriate for the Validation of Influenza Pseudotype Neutralization Assays
por: Ferrara, Francesca, et al.
Publicado: (2017)

COVID-19 and Hyperimmune sera: A feasible plan B to fight against coronavirus
por: da Costa, Camila B.P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bmkv2bku920v98hkeeomtgim1i